-+ 0.00%
-+ 0.00%
-+ 0.00%

William Blair Downgrades Verve Therapeutics to Market Perform

Benzinga·06/17/2025 14:59:41
Listen to the news
William Blair analyst Myles Minter downgrades Verve Therapeutics (NASDAQ:VERV) from Outperform to Market Perform.